Guardian Pharmacy Services Inc
NYSE:GRDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guardian Pharmacy Services Inc
NYSE:GRDN
|
US |
|
C
|
Curvebeam AI Ltd
ASX:CVB
|
US |
|
A
|
ABC SA
SGO:ABC
|
CL |
|
Arteris Inc
NASDAQ:AIP
|
US |
|
Marel hf
AEX:MAREL
|
IS |
|
Bird Construction Inc
TSX:BDT
|
CA |
|
Nordic Iron Ore AB
F:NIO
|
SE |
|
Grupo Aval Acciones y Valores SA
NYSE:AVAL
|
CO |
|
Mary Chia Holdings Ltd
SGX:5OX
|
SG |
|
N
|
Nokia Oyj
PAR:NOKIA
|
FI |
Wall Street
Price Targets
GRDN Price Targets Summary
Guardian Pharmacy Services Inc
According to Wall Street analysts, the average 1-year price target for GRDN is 39.27 USD with a low forecast of 38.38 USD and a high forecast of 42 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GRDN's stock price target?
Price Target
39.27
USD
According to Wall Street analysts, the average 1-year price target for GRDN is 39.27 USD with a low forecast of 38.38 USD and a high forecast of 42 USD.
What is Guardian Pharmacy Services Inc's Revenue forecast?
Projected CAGR
5%
For the last 5 years the compound annual growth rate for Guardian Pharmacy Services Inc's revenue is 15%. The projected CAGR for the next 3 years is 5%.
What is Guardian Pharmacy Services Inc's Operating Income forecast?
Projected CAGR
18%
For the last 5 years the compound annual growth rate for Guardian Pharmacy Services Inc's operating income is 17%. The projected CAGR for the next 3 years is 18%.
What is Guardian Pharmacy Services Inc's Net Income forecast?
Projected CAGR
22%
For the last 5 years the compound annual growth rate for Guardian Pharmacy Services Inc's net income is 20%. The projected CAGR for the next 3 years is 22%.
